NCT02334384
- Conditions
- Animal Diseases, Bacterial Infections, Bacterial Infections and Mycoses, +10 more
- Locations
-
- Sentara Norfolk General Hospital Norfolk, Virginia, United States
Clinical trial condition
Staphylococcal Infections
Explore clinical trials studying Staphylococcal Infections. Study availability and eligibility vary by location and protocol.
52 public trials
2 recruiting studies
Staphylococcal Infections trial results
NCT01419184
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +7 more
- Locations
-
- Mobile, Alabama, United States
- Chula Vista, California, United States
- Escondido, California, United States
- La Mesa, California, United States
NCT03429595
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- AntibioTx Investigational Site Bloemfontein, South Africa
- AntibioTx Investigative Site Boksburg, South Africa
- AntibioTx Investigative Site Claremont, South Africa
- AntibioTx Investigative Site Durban, South Africa
NCT01523899
- Conditions
- Animal Diseases, Bacterial Infections, Bacterial Infections and Mycoses, +11 more
- Locations
-
- The George Washington University Washington D.C., District of Columbia, United States
- Johns Hopkins University Baltimore, Maryland, United States
NCT00852540
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +16 more
- Locations
-
- GSK Investigational Site Anniston, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Bentonville, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
NCT00133874
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +16 more
- Locations
-
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site St. John's, Newfoundland and Labrador, Canada
- GSK Investigational Site Brampton, Ontario, Canada
NCT00555061
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Cellulitis, +23 more
- Locations
-
- GSK Investigational Site Tuscaloosa, Alabama, United States
- GSK Investigational Site Bentonville, Arkansas, United States
- GSK Investigational Site Orange, California, United States
- GSK Investigational Site Woburn, Massachusetts, United States
Completed
Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
NCT02582203
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +7 more
- Locations
-
- Detroit Medical Center Detroit, Michigan, United States
- St. John Hospital and Medical Center Detroit, Michigan, United States
- Henry Ford Hospital Detroit, Michigan, United States
NCT00133848
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- GSK Investigational Site Bangalore, India
- GSK Investigational Site Hyderabad, India
- GSK Investigational Site Rome, Lazio, Italy
- GSK Investigational Site Zapopan, Jalisco, Jalisco, Mexico
Completed
Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
NCT01397461
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +9 more
- Locations
-
- Georg Popp Augsburg, Germany
- Klaus Chelius Cologne, Germany
- Roland Aschoff Dresden, Germany
- Diamant Thaci Frankfurt am Main, Germany